Antigenicity analysis of the recombinant outer membrane NlpI protein of Mannheimia haemolytica
- PMID: 40596169
- PMCID: PMC12218578
- DOI: 10.1038/s41598-025-05125-7
Antigenicity analysis of the recombinant outer membrane NlpI protein of Mannheimia haemolytica
Abstract
To explore the antigenic characteristics of the NlpI protein. This study screened a potential antigen of Mannheimia haemolytica using NCBI Blast analysis and investigated its immunogenicity using online software. The recombinant NlpI protein (rNlpI) was expressed in prokaryotic cells, and its reactogenicity was detected by western blot. The transcription level of nlpI mRNA in M. haemolytica after various culture durations was determined by RT-qPCR. Mice were challenged with M. haemolytica strain 95 at an LD50 dose, and their serum was collected at various times. The rNlpI protein in M. haemolytica and western blot were used to detect the expression of antibodies specific to rNlpI. BALB/c mice were immunized with various protein doses and white oil adjuvant on days 0, 7, and 14, and the antibody titer was detected by indirect ELISA. Cytokines were detected by double antibody sandwich ELISA. Seven days after the third immunization, M. haemolytica strain 95 was injected intraperitoneally at 3 × 108 CFU/mouse. After 48 h, the surviving mice were dissected and the bacterial load in their lungs was assessed. NlpI is a hydrophilic and soluble protein with a transmembrane domain, 11 antigenic determinants, and 27 B cell epitopes. It was speculated that the protein has strong immunogenicity. The expressed NlpI protein could bind to bovine serum positive for M. haemolytica. The transcription level of the nlpI gene was the highest in the stable phase, followed in decreasing order by the logarithmic, slow, and decline phases. The expression levels in the various phases differed insignificantly. The IgG antibody titers of mice immunized with 10, 20, and 30 µg NlpI + white oil adjuvant and 30 µg NlpI were measured. The antibody level of the 30 µg NlpI + white oil adjuvant group was higher than that in the other groups (P < 0.001). The immune protection rates of the 10 µg rNlpI + white oil adjuvant and 30 µg rNlpI groups were under 30%, while they were 50% and 60%, respectively, in the 20 and 30 µg rNlpI + white oil adjuvant groups. The bacterial load of all immunized groups was 99.99% lower than in the PBS and white oil adjuvant control groups. The protection rates differed significantly among immunized groups (P < 0.001), with the 30 µg rNlpI + white oil adjuvant group showing the lowest bacterial load in the lungs. The rNlpI protein can react with bovine M. haemolytica positive blood with good reactogenicity, and can induce mice to produce high titers of specific IgG antibodies, effectively resisting homologous strain invasion. The results lay a good foundation for developing new M. haemolytica vaccines.
Keywords: Mannheimia haemolytica; Antigenicity; Bioinformatics characteristic; NlpI protein; Prokaryotic expression; Transcription level.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures










Similar articles
-
Comparison of total IgG and neutralizing antibody responses to a novel trivalent recombinant Mannheimia haemolytica vaccine containing serotype 6.Microb Pathog. 2025 Oct;207:107875. doi: 10.1016/j.micpath.2025.107875. Epub 2025 Jul 5. Microb Pathog. 2025. PMID: 40623483
-
[Preliminary study on the biological characteristics of heat shock cognate protein 20 of Schistosoma japonicum].Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2025 May 7;37(3):294-303. doi: 10.16250/j.32.1915.2024254. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2025. PMID: 40730528 Chinese.
-
Mucosal colonization of Mannheimia haemolytica capsular and adhesin mutants in cattle.Microbiol Spectr. 2025 Jul;13(7):e0068425. doi: 10.1128/spectrum.00684-25. Epub 2025 May 22. Microbiol Spectr. 2025. PMID: 40401934 Free PMC article.
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079. Health Technol Assess. 2024. PMID: 39046101 Free PMC article.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
References
-
- Feedlot Part IV: health and health management on U.S. feedlots with a capacity of 1000 or more head. USDA-APHIS-VS-CEAH-NAHMS, 2013. (2011).
-
- Death loss in U.S. Cattle and Calves Due To Predator and Nonpredator Causes, 2015 (USDA-APHIS-VS-CEAH-NAHMS, 2017).
-
- Ayalew, S. et al. Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates. Proteomics10 (11), 2151–2164 (2010). - PubMed
MeSH terms
Substances
Grants and funding
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2023NY03-1/Corps eighth division key areas of science and technology research projects
- 2024AB035/Corps key areas of science and technology research
- 2021AB012/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2021AB012/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
- 2024AB035/Corps key areas of science and technology research
LinkOut - more resources
Full Text Sources
Research Materials